Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2026-02-23 @ 6:27 AM
Study NCT ID:
NCT02275156
Status:
COMPLETED
Last Update Posted:
2022-11-07
First Post:
2014-07-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08-19
Start Date Type:
ACTUAL
Primary Completion Date:
2014-12-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12-19
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-15
First Submit QC Date:
None
Study First Post Date:
2014-10-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-08
Results First Submit QC Date:
None
Results First Post Date:
2016-01-29
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-03
Last Update Post Date:
2022-11-07
Last Update Post Date Type:
ACTUAL